history of glp-1 agonists Reflections on the discovery as a satiety hormone: Implications for obesity therapy and future directions GLP-1 Receptor Agonists as Treatments
Description
Learn about the Ozempic blindness lawsuit, including NAION and other vision problems, and read about the study linking semaglutide use to severe eye problems.

Ozempic and Wegovy users focus on nausea and vomiting

The global obesity treatment market is expanding at unprecedented speed, with sales of weight-loss medications forecast to rise dramatically over the next decade.

This systematic review and meta-analysis evaluated the efficacy and safety of traditional GLP-1 RAs, DPP-4is, and SGLT-2is compared with insulin

American Diabetes Association
